Save time and jump to the most important pieces.
4 - Grindr Inc. (0001820144) (Issuer)
4 - Grindr Inc. (0001820144) (Issuer)
4/A - Grindr Inc. (0001820144) (Issuer)
The social networking platform sets its go-forward leadership team ahead of public listing to continue and accelerate profitable growth The Board of Directors of Grindr (the "Board"), the #1 social network for the LGBTQ community, today announced that George Arison, one of the few openly gay public company CEOs in the US, has been named Grindr's new Chief Executive Officer effective October 19, 2022. Additionally, Vanna Krantz, former CFO of Disney Streaming Services, has been appointed Chief Financial Officer, effective September 26, 2022. This leadership announcement is part of a planned transition – originally announced along with the SPAC transaction in May – as Grindr prepares for its
Tiga Acquisition Corp. (the "Company"), a blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses (a "Business Combination"), announced today that it has approved an extension of the time period to consummate a Business Combination, in accordance with Article 49.8 of the Company's Amended and Restated Memorandum and Articles of Association, to and including November 27, 2022. In connection therewith, the Company has also approved the issuance and sale of, to Tiga Sponsor LLC (the "Sponsor"), an additional 2,760,000 private placement warrants at $1.00 per w
Tiga Acquisition Corp. (the "Company"), announced today that on November 23, 2021 it issued and sold to Tiga Sponsor LLC 2,760,000 private placement warrants at $1.00 per warrant for an aggregate purchase price of US$2,760,000 (the "Proceeds"), and that such Proceeds were placed on deposit in the Company's Trust Account on November 22, 2021. Each warrant entitles the holder thereof to purchase one Class A ordinary share at a price of $11.50 per share. This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to
EFFECT - Grindr Inc. (0001820144) (Filer)
EFFECT - Grindr Inc. (0001820144) (Filer)
8-K - Grindr Inc. (0001820144) (Filer)
4 - Grindr Inc. (0001820144) (Issuer)
4/A - Grindr Inc. (0001820144) (Issuer)
4 - Grindr Inc. (0001820144) (Issuer)
SC 13D/A - Grindr Inc. (0001820144) (Subject)
SC 13D/A - Grindr Inc. (0001820144) (Subject)
SC 13D/A - Grindr Inc. (0001820144) (Subject)
The social networking platform sets its go-forward leadership team ahead of public listing to continue and accelerate profitable growth The Board of Directors of Grindr (the "Board"), the #1 social network for the LGBTQ community, today announced that George Arison, one of the few openly gay public company CEOs in the US, has been named Grindr's new Chief Executive Officer effective October 19, 2022. Additionally, Vanna Krantz, former CFO of Disney Streaming Services, has been appointed Chief Financial Officer, effective September 26, 2022. This leadership announcement is part of a planned transition – originally announced along with the SPAC transaction in May – as Grindr prepares for its
Gainers Fast Radius, Inc. (NASDAQ:FSRD) shares surged 106.3% to close at $0.21 on Wednesday after dipping around 48% on Tuesday. Fast Radius established a timeline for a Chapter 11 sale process. InMed Pharmaceuticals Inc. (NASDAQ:INM) shares gained 36.3% to settle at $3.79. InMed Pharmaceuticals advanced neurodegenerative disease program with Natural Sciences and Engineering Research Council of Canada alliance grant funding. Foresight Autonomous Holdings Ltd. (NASDAQ:FRSX) jumped 33% to close at $0.7199 after the company announced it signed a commercial agreement with SUNWAY-AI for up to $51 million. Ensysce Biosciences, Inc. (NASDAQ:ENSC) gained 29.2% to settle at $2.79. Zacks Small-
Gainers Fast Radius, Inc. (NASDAQ:FSRD) shares jumped 109% to $0.2115 after dipping around 48% on Tuesday. Fast Radius established a timeline for a Chapter 11 sale process. InMed Pharmaceuticals Inc. (NASDAQ:INM) shares climbed 60.5% to $4.4613. InMed Pharmaceuticals advanced neurodegenerative disease program with Natural Sciences and Engineering Research Council of Canada alliance grant funding. Tiga Acquisition Corp. (NASDAQ:TINV) gained 35.1% to $13.75. Exagen Inc. (NASDAQ:XGN) jumped 29% to $3.86. Exagen reported better-than-expected Q3 EPS and sales results and issued FY22 revenue guidance above estimates. Lizhi Inc. (NASDAQ:LIZI) gained 18% to $0.85 after the company swung to a